Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Moser, H. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moser, H. W.
Right arrowPubmed/NCBI databases
*Substance via MeSH
*Genetics Home Reference
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Adrenoleukodystrophy: From Bedside to Molecular Biology

Hugo W. Moser, MD

Kennedy Institute for Handicapped Children and the Departments of Neurology and Pediatrics, Johns Hopkins University, Baltimore, MD

Although X-linked adrenoleukodystrophy was first described in 1923, the key advances in understanding the disorder followed discoveries beginning in 1973 that it was characterized by the tissue accumulation of very long chain fatty acids, particularly hexacosanoic acid (C26:0). Very long chain fatty acid assays in plasma, red cells, fibroblasts, or amniocytes permit prenatal and postnatal diagnosis and carrier detection. The phenotype of X-linked adrenoleukodystrophy is varied and ranges from the severe and fatal childhood form, to persons who remain asymptomatic in adult life. The underlying biochemical defect is the impaired capacity to degrade very long chain fatty acids, a reaction which normally takes place in the peroxisome. The locus of the adrenoleukodystrophy gene has been mapped to the terminal (Q28) segment of the long arm of the X-chromosome, in close proximity to the loci of Hemophilia A and red-green color blindness. A DNA probe (St14) for this portion of the X-chromosome is of aid for carrier detection. A new dietary regimen, which combines restricted very long chain fatty acid intake with the administration of a glycerol trioleate oil, is capable of reducing plasma very long chain fatty acid levels, and may offer neurological benefit. (j Child Neurol 1987;2:140-150).

Journal of Child Neurology, Vol. 2, No. 2, 140-150 (1987)
DOI: 10.1177/088307388700200211
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Arch NeurolHome page
P. J. Willems, L. Vits, R. J. A. Wanders, P. J. Coucke, B. J. Van der Auwera, A. F. Van Elsen, P. Raeymaekers, C. Van Broeckhoven, R. B. H. Schutgens, G. Dacremont, et al.
Linkage of DNA Markers at Xq28 to Adrenoleukodystrophy and Adrenomyeloneuropathy Present Within the Same Family
Arch Neurol, June 1, 1990; 47(6): 665 - 669.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
R. A. Brumback, J. B. Bodensteiner, and R. M. Shuman
The Journal of Child Neurology and Child Neurology: Growing Together
J Child Neurol, October 1, 1988; 3(4): 232 - 274.
[PDF]